S

S.M. Gadgeel

Henry Ford Health System

Publishes on Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment. 4 papers and 101 citations.

4Publications

101Total Citations

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Gastric Cancer Management and Outcomes Monoclonal and Polyclonal Antibodies Research

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

Enriqueta Felip, Byoung Chul Cho, V. Gutiérrez et al.|Annals of Oncology|2024

Cited by 81Open Access

OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update

D.R. Spigel, M-J. Ahn, M. Majem et al.|Journal of Thoracic Oncology|2024

Cited by 8Open Access

MA12.07 Amivantamab Plus Lazertinib vs Osimertinib in First-Line, EGFR-Mutant Advanced NSCLC: Patient-relevant Outcomes from MARIPOSA

Danny Nguyen, B. Besse, B.C. Cho et al.|Journal of Thoracic Oncology|2024

Cited by 7Open Access

1549TiP DeLLphi-303: Phase Ib first-line combination study of tarlatamab, a DLL3-targeting half-life extended bispecific T-cell engager (HLE BiTE®), with carboplatin, etoposide, and PD-L1 inhibition in extensive stage small cell lung cancer (ES-SCLC)

S.M. Gadgeel, J. Al-Mondhiry, M-J. Ahn et al.|Annals of Oncology|2022

Cited by 5